XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCK-BASED COMPENSATION AND EQUITY (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Total Stock-Based Compensation Expense The following table details total stock-based compensation expense for the three and nine months ended September 30, 2022 and 2021, included in the condensed consolidated statements of income:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands)2022202120222021
Costs of sales$274 $311 $851 $793 
Operating expenses1,590 1,389 4,433 3,386 
Pre-tax stock-based compensation expense1,864 1,700 5,284 4,179 
Less: income tax effect(410)(374)(1,162)(919)
Net stock-based compensation expense$1,454 $1,326 $4,122 $3,260 
Summary of Restricted Stock Activity
A summary of restricted stock activity under the Plan during the nine months ended September 30, 2022 and 2021 is as follows:
Nine Months Ended September 30, 2022Nine Months Ended September 30, 2021
SharesWeighted-Average
Grant Date
Fair Value Per Share
SharesWeighted-Average
Grant Date
Fair Value Per Share
Unvested restricted stock outstanding at beginning of period314,883 $29.79 412,967 $28.87 
Granted161,375 34.22 153,700 31.22 
Vested(181,405)29.79 (245,455)29.16 
Forfeited(8,936)31.60 (6,329)29.10 
Unvested restricted stock outstanding at end of period285,917 $32.23 314,883 $29.79 
Summary of Performance Share Award Activity
A summary of performance share award activity under the Plan during the nine months ended September 30, 2022 and 2021 is as follows, based on the target award amounts set forth in the performance share award agreements:
Nine Months Ended September 30, 2022Nine Months Ended September 30, 2021
SharesWeighted-Average
Grant Date
Fair Value Per Share
SharesWeighted-Average
Grant Date
Fair Value Per Share
Performance share awards outstanding at beginning of period249,952 $29.59 252,852 $29.27 
Granted101,799 37.98 93,444 31.26 
Forfeited or unearned(45,060)31.70 (20,373)29.92 
Earned and issued(27,317)31.75 (75,971)30.50 
Performance share awards outstanding at end of period279,374 $32.09 249,952 $29.59